A hospitalwide intervention program to optimize the quality of antibiotic use:: Impact on prescribing practice, antibiotic consumption, cost savings, and bacterial resistance

被引:172
作者
Bantar, C
Sartori, B
Vesco, E
Heft, C
Saúl, M
Salamone, F
Oliva, ME
机构
[1] Hosp San Martin, Comm Prevent & Control Nosocomial Infect, Parana, Entre Rios, Argentina
[2] Hosp San Martin, Dept Pharm, Parana, Entre Rios, Argentina
[3] Hosp San Martin, Dept Internal Med, Parana, Entre Rios, Argentina
[4] Hosp San Martin, Dept Microbiol, Parana, Entre Rios, Argentina
关键词
D O I
10.1086/375818
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Several findings from Argentina provide compelling evidence of the need for more rational use of antimicrobial agents. Thus, a multidisciplinary antimicrobial treatment committee for the development of a hospital-wide intervention program was formed to optimize the quality of antibiotic use in hospitals. Four successive steps were developed during 6-month periods: baseline data collection, introduction of a prescription form, education, and prescribing control. Sustained reduction of drug consumption was shown during the study (R-2=0.6885; P=.01). Total cost savings was US$913,236. To estimate the consumption of cefepime and aminopenicillin-sulbactam in relation to that of the third-generation cephalosporins, 2 indices were calculated: Icfp and Iams, respectively. Decreasing resistance to ceftriaxone by Proteus mirabilis and Enterobacter cloacae proved to be associated with increasing Icfp. Decreasing rates of methicillin-resistant Staphylococcus aureus were related to increasing Iams. The present study indicates that a systematic program performed by a multidisciplinary team is a cost-effective strategy for optimizing antibiotic prescribing.
引用
收藏
页码:180 / 186
页数:7
相关论文
共 31 条
  • [1] Bantar C, 2000, Int J Infect Dis, V4, P85
  • [2] Bantar C, 2001, 101 GEN M AM SOC MIC, P17
  • [3] Improved antimicrobial interventions have benefits
    Barenfanger, J
    Short, MA
    Groesch, AA
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (08) : 2823 - 2828
  • [4] Effect of changes in antibiotic prescribing on patient outcomes in a community setting: A natural experiment in Australia
    Beilby, J
    Marley, J
    Walker, D
    Chamberlain, N
    Burke, M
    [J]. CLINICAL INFECTIOUS DISEASES, 2002, 34 (01) : 55 - 64
  • [5] Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella species:: Risk factors for colonization and impact of antimicrobial formulary interventions on colonization prevalence
    Bisson, G
    Fishman, NO
    Patel, JB
    Edelstein, PH
    Lautenbach, E
    [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2002, 23 (05) : 254 - 260
  • [6] Alarming baseline rates of nosocomial infection and surgical prophylaxis errors in a small teaching hospital in Argentina
    Bustos, JL
    Vesco, E
    Tosello, C
    Almará, A
    Boleas, M
    Magnin, E
    Salamone, F
    Sartori, B
    Morera, G
    Bantar, C
    [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2001, 22 (05) : 264 - 265
  • [7] Emergence of antibiotic-resistant Pseudomonas aeruginosa:: Comparison of risks associated with different antipseudomonal agents
    Carmeli, Y
    Troillet, N
    Eliopoulos, GM
    Samore, MH
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (06) : 1379 - 1382
  • [8] Antecedent treatment with different antibiotic agents as a risk factor for vancomycin-resistant enterococcus
    Carmeli, Y
    Eliopoulos, GM
    Samore, MH
    [J]. EMERGING INFECTIOUS DISEASES, 2002, 8 (08) : 802 - 807
  • [9] AMPICILLIN, SULBACTAM, AND RIFAMPIN COMBINATION TREATMENT OF EXPERIMENTAL METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS ENDOCARDITIS IN RABBITS
    CHAMBERS, HF
    KARTALIJA, M
    SANDE, M
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (04) : 897 - 902
  • [10] DESANTIS G, 1994, MED J AUSTRALIA, V160, P502